Cellular atlas of amygdala reveals new treatment target for cocaine addiction

Researchers at University of California San Diego School of Medicine and the Salk Institute for Biological Studies have created a unique, cell-by-cell atlas of the amygdala, a small structure deep within the brain that plays a crucial role in controlling emotional responses to drugs. The findings, published in Nature Neuroscience, helped the researchers identify a potential new treatment for cocaine addiction, a disease that is poorly understood at the molecular level and has virtually no approved pharmacological treatments.

Mice experiments show early life adversity mental problems can be passed down three generations

A combined team of psychiatrists and brain researchers from the University of Toronto and Québec Mental Health Institute in the Canada, working with a colleague from the National Research Council’s Institute of Biochemistry and Cell Biology, in Italy, has found that neurological problems associated with early life adversity (ELA) can be passed down at least three generations in mice.

Gene therapy opens new possibilities for treating chronic pain

Researchers from the Nuffield Department of Clinical Neurosciences at the University of Oxford, along with colleagues at Cambridge University and Barts and the London School of Medicine and Dentistry, have shown the potential of a new gene therapy approach to silence human sensory neurons (nerve cells) as a means of treating persistent pain. Many current drugs for chronic pain are highly addictive, which makes it important to discover new alternatives.